Selected article for: "recombinant antigen and spike protein"

Author: Zhi, Yan; Kobinger, Gary P.; Jordan, Heather; Suchma, Katie; Weiss, Susan R.; Shen, Hao; Schumer, Gregory; Gao, Guangping; Boyer, Julie L.; Crystal, Ronald G.; Wilson, James M.
Title: Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein
  • Cord-id: a8pixbuc
  • Document date: 2005_4_25
  • ID: a8pixbuc
    Snippet: The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major
    Document: The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436–443 and S525–532) and one H-2(d)-restricted epitope (S366–374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and adenoviral vaccine vector: 1, 2, 3
    • acute respiratory syndrome and adenoviral vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and adenoviral vector encoding spike protein: 1, 2
    • acute respiratory syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung tissue sample: 1, 2
    • acute respiratory syndrome and lysis buffer: 1, 2, 3
    • lung tissue and lysis buffer: 1, 2, 3